详细信息

黄芪多糖联合顺铂抑制小鼠Lewis肺癌移植瘤生长及其机制     被引量:4

Inhibitory effect and the mechanism of Astragalus polysaccharide combined with cisplatin on growth of inplanted Lewis lung carcinoma in mice

文献类型:期刊文献

中文题名:黄芪多糖联合顺铂抑制小鼠Lewis肺癌移植瘤生长及其机制

英文题名:Inhibitory effect and the mechanism of Astragalus polysaccharide combined with cisplatin on growth of inplanted Lewis lung carcinoma in mice

作者:庄梦婕[1,2];刘丹[1,2];陈彦文[1];明海霞[1,2,3];李阳[1]

第一作者:庄梦婕

机构:[1]甘肃中医药大学;[2]甘肃省高校重大疾病分子医学与中医药防治研究重点实验室;[3]甘肃省中药药理与毒理学重点实验室

第一机构:甘肃中医药大学

年份:2017

卷号:33

期号:4

起止页码:503

中文期刊名:细胞与分子免疫学杂志

外文期刊名:Chinese Journal of Cellular and Molecular Immunology

收录:MEDLINE(收录号:28395722);CSTPCD;;Scopus;北大核心:【北大核心2014】;CSCD:【CSCD2017_2018】;PubMed;

基金:甘肃省高校基本科研业务项目(2014);甘肃省科技厅计划项目(148RJZA060);兰州市科技局计划项目(2014-1-23)

语种:中文

中文关键词:黄芪多糖(APS);Lewis肺癌;顺铂;细胞色素C;丝氨酸蛋白酶

外文关键词:Astraga/us polysaccharides; Lewis lung cancer; cisplatin (DDP) ; cytochrome C (CytC) ; OmVHtrA2

摘要:目的观察黄芪多糖(APS)及联合顺铂(DDP)对Lewis肺癌(LLC)移植瘤小鼠凋亡蛋白细胞色素C(CytC)和高温必需丝氨酸蛋白酶A2(Omi/HtrA2)表达的影响。方法 90只C57BL/6J小鼠,随机分为正常组、模型组、(50、100、200)μg/mL APS处理组、6 mg/kg DDP处理组、3 mg/kg DDP联合(50、100、200)μg/mL APS处理组,每组10只。除正常组外,其余80只均接种1×107LLC细胞0.2 mL于右前肢腋窝皮下,建立荷瘤小鼠模型。造模次日起,治疗组的小鼠给予腹腔注射0.3 mL药物。每周注射1次DDP,其余药物每天1次,正常组和模型组注射等体积生理盐水,连续20 d,于第21天处死。采用HE染色观察肿瘤组织病变情况;免疫组织化学染色和图像分析法检测移植瘤细胞中的Cyt C及Omi/HtrA2的表达和定位。结果 (100、200)μg/mL APS处理及3 mg/kg DDP联合(100、200)μg/mL APS的荷瘤小鼠肿瘤质量减轻。与模型组小鼠比较,200μg/mL APS联合3 mg/kg DDP小鼠的肿瘤细胞坏死最为明显,各处理组的肿瘤组织中Cyt C、Omi/Htr A2蛋白水平均增加,200μg/mL APS联合3 mg/kg DDP小鼠的肿瘤组织增加最明显。结论APS及联合DDP能抑制小鼠Lewis肺癌细胞的生长,可能与肿瘤细胞Cyt C、Omi/Htr A2表达增加有关。
Objective To observe the effect of Astragalus polysaccharides (APS) combined with cisplatin (DDP) on the expressions of cytochrome C (CytC) and high temperature required sedne protease A2 (Omi/HtrA2) in the mice with Lewis lung carcinoma (LLC) transplantated tumors. Methods Ninty C57BL/6J mice were randomly divided into normal control group, model group, and (50, 100,200) μg/mL APS groups, 6 mg/kg DDP group, 3 mg/kg DDP combined with (50, 100, 200)μg/mL APS groups. Each group included 10 mice. Except the mice in the normal group, the rest mice were inoculated subcutaneously with LLC cells ( 1× 10^7 mL) at the right fore axillary fossa to establish tumor-bearing mouse models. In the second day of building models, the mice in the treatment group were given intraperitoneal injection of 0. 3 mL of the drug. DDP was given once a week, and the other drugs once a day. The mice in the normal group and the model group were administrated the same amount of saline injection for continuous 20 days. All mice were killed at the 21st day. The pathological changes of tumor tissues were observed by HE staining. The expressions and location of CytC and Omi/HtrA2 proteins in the transplanted tumor tissues were detected by immunohistochemical staining and image analysis. Results The mass of tumor decreased in the mice of (100,200) μg/mL APS group and 3 mg/kg DDP combined with (100, 200) μg/mL APS group. Compared with the model group, the necrosis of tumor tissues in 200 μg/mL APS combined with 3 mg/kg DDP group was the most obvious. The expressions of CytC and Omi/HtrA2 increased in the treatment groups, and the increase was the most remarkable in 200 μg/mL APS combined with 3 mg/kg DDP group. Conclusion APS and APS combined with DDP can restrain the growth of Lewis Lung cancer in C57BL/6J mice, which may be related to the increased expressions of CytC and OmVHtrA2.

参考文献:

正在载入数据...

版权所有©甘肃中医药大学 重庆维普资讯有限公司 渝B2-20050021-8 
渝公网安备 50019002500408号 违法和不良信息举报中心